Wow. They have apparently abandoned any pretense of IV / sepsis efficacy now.
US commercialisation -- for an antiseptic spray -- is now 2028, at best?!
Not a mention of burns trial.
This is the one of the saddest things I have ever read.
And these dodgy results in P2 ABSSSI - not even a 50% cure rate. Is that enough to even warrant P3?!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $104.1M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.0¢ | 34.0¢ | $49.52K | 143.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2727 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 1921 | 1 |
View Market Depth
| Last trade - 10.37am 22/07/2025 (20 minute delay) ? |
| RCE (ASX) Chart |